Ardelyx, Inc.
Waltham, MA
- UEI
- YLYTCEN9K617
- CAGE
- 59BW4
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 400 5th Ave #210, Waltham, MA 02451, USA
- Website
- ardelyx.com
- Founded
- 2007
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $21,946 |
| FY2025 | $20,167 |
| FY2024 | $18,146 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $21,946 |
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Xphozah 30 MG | Veterans Integrated Service Network 5 (VHA) | $11,948 | |
| Xphozah 30 MG | Veterans Integrated Service Network 5 (VHA) | $1,991 | |
| Xphozah 20 MG | Veterans Integrated Service Network 5 (VHA) | $3,999 | |
| Xphozah 30 MG | Veterans Integrated Service Network 5 (VHA) | $1,991 | |
| Xphozah 30 MG | Veterans Integrated Service Network 5 (VHA) | $2,017 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Jazz Pharmaceuticals, Inc. | Menlo Park, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Arrowhead Pharmaceuticals, Inc. | Pasadena, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Ferring Pharmaceuticals Inc. | Parsippany-Troy Hills, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Travere Therapeutics, Inc. | San Diego, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Incyte Corporation | Wilmington, DE | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Ardelyx, Inc., a for-profit pharmaceutical company based in Fremont, California, supplies specialized medications to the Department of Veterans Affairs as a prime contractor under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), competing full-and-open without set-aside designation. The company holds a single-award $32.5 million Blanket Purchase Agreement awarded by the National Acquisition Center on April 30, 2024, running through April 29, 2027, and a multi-award Federal Supply Schedule contract with Veterans Integrated Service Network 12 valued at $300 thousand through June 2027.
Ardelyx's federal footprint centers on XPHOZAH (tenapanor), a specialized medication for treating hyperphosphatemia in dialysis patients. Recent delivery orders reflect consistent demand across multiple VISNs: a $1,991.36 order from VISN 5 on April 9, 2026; a $16,133.49 order from VISN 20 on October 1, 2024; and multiple emergency orders to VISN 9 (including $6,048.81 orders in March and April 2024). Individual delivery orders typically range from $2,016 to $16,133, with firm fixed pricing and ultimate completion dates aligned to near-term fulfillment (within days to weeks of award). Performance occurs across VA medical centers in Dublin, Ohio; Bartlett, Tennessee; and other geographic locations supporting multiple VISNs.
Customer concentration is entirely within the Department of Veterans Affairs Veterans Health Administration. The National Acquisition Center anchors the portfolio with the $32.5 million BPA (98% of combined potential value); subordinate orders flow through five regional VISNs (5, 9, 12, 20, and 21), accounting for the remaining $325 thousand in potential value across 13 delivery orders. The vendor has served six distinct VA entities since first registering on SAM.gov in December 2011, with documented activity beginning in 2022.
Award activity shows two distinct phases: an initial period of two awards in 2022 (the BPA IDV and an interim FSS agreement), followed by five delivery orders in 2024, three in 2025, and four in 2026 through mid-year. Combined potential value across all 14 awards stands at $32.9 million, with only $60 thousand obligated to date — reflecting the BPA structure where most dollars remain unexercised pending individual VISN delivery orders. The company operates as a 100% prime contractor footprint with no subcontract work in the source data.
Quick answers
Is Ardelyx, Inc. registered in SAM.gov?
Yes. Ardelyx, Inc.'s SAM.gov registration is active through January 9, 2027.
What is Ardelyx, Inc.'s CAGE code?
Ardelyx, Inc.'s CAGE code is 59BW4, and its Unique Entity ID (UEI) is YLYTCEN9K617.
Which contract vehicles does Ardelyx, Inc. hold?
Ardelyx, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Ardelyx, Inc. received in federal contracts?
Federal contracts obligated $20,167 to Ardelyx, Inc. in fiscal year 2025 and $60,259 in fiscal years 2023 through 2027.
What is Ardelyx, Inc.'s most recent federal award?
Ardelyx, Inc.'s most recent federal contract award is Xphozah 30 MG (36C24526N0689), from Veterans Integrated Service Network 5 (VHA), on June 26, 2026.
On GovTribe
See Ardelyx, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors